The Role of Mobile Technology in Surveillance of Adverse Events Following Immunization during New Vaccines Introduction in Cameroon: A Cross-Sectional Study

Authors: A. A. Njoh, S. T. Ndoula, A. Adidja, G. N. Menan, A. Mengue, E. Mboke, H. B. Bachir, S. C. Nchinjoh, L. Adisso, Y. Saidu, L. Cleenewerck de Kiev

Abstract:

Vaccines serve a great deal in protecting the population globally. Vaccine products are subject to rigorous quality control and approval before use to ensure safety. Even if all actors take the required precautions, some people could still have adverse events following immunization (AEFI) caused by the vaccine composition or an error in its administration. AEFI underreporting is pronounced in low-income settings like Cameroon. The Country introduced electronic platforms to strengthen surveillance. With the introduction of many novel vaccines, like COVID-19 and the novel Oral Polio Vaccine (nOPV) 2, there was a need to monitor AEFI in Cameroon. A cross-sectional study was conducted from July to December 2022. Data on AEFI per region of Cameroon were reviewed for the previous five years. Data were analyzed with MS Excel, and the results were presented in proportions. AEFI reporting was uncommon in Cameroon. With the introduction of novel vaccines in 2021, the health authorities engaged in new tools and training to capture cases. AEFI detected almost doubled using the open data kit (ODK) compared to previous platforms, especially following the introduction of the nOPV2 and COVID-19 vaccines. The AEFI rate was 1.9 and 160 per administered 100,000 doses of nOPV2 and COVID-19 vaccines, respectively. This mobile tool captured individual information for people with AEFI from all regions. The platform helped to identify common AEFI following the use of these new vaccines. The ODK mobile technology was vital in improving AEFI reporting and providing data to monitor the use of new vaccines in Cameroon.

Keywords: Adverse events following immunization, AEFI, Cameroon, COVID-19 vaccines, novel oral polio vaccine 2, open data kit.

References:

[1] WHO (2012) Adverse events following immunization (AEFI). https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/health-professionals-info/aefi. Accessed 24 Jun 2022
[2] CDC (2022) Immunization Basics | CDC. https://www.cdc.gov/vaccines/vac-gen/imz-basics.htm. Accessed 20 Apr 2022
[3] WHO (2010) Yellow fever: Surveillance of adverse events following immunization against yellow fever. WHO, 20 Avenue Appia, 1211 Geneva 27, Switzerland.
[4] Parrella A, Braunack-Mayer A, Gold M, Marshall H, Baghurst P (2013) Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Serv Res 13:313
[5] Izurieta HS, Zuber P, Bonhoeffer J, et al. (2013) Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines. Vaccine 31:3623–3627
[6] Tsafack M, Ateudjieu J (2015) Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial. Pan Afr Med J 22:351
[7] Dinga JN, Njoh AA, Gamua SD, Muki SE, Titanji VPK (2022) Factors Driving COVID-19 Vaccine Hesitancy in Cameroon and Their Implications for Africa: A Comparison of Two Cross-Sectional Studies Conducted 19 Months Apart in 2020 and 2022. Vaccines (Basel) 10:1401
[8] Mascola JR, Fauci AS (2020) Novel vaccine technologies for the 21st century. Nat Rev Immunol 20:87–88
[9] Njoh AA, Saidu Y, Bachir HB, et al. (2022) Impact of periodic intensification of routine immunization within an armed conflict setting and COVID-19 outbreak in Cameroon in 2020. Conflict and Health 16:29
[10] Amani A, Djossaya D, Njoh AA, Fouda AAB, Ndoula S, Abba-kabir HM, Mossus T, Nguefack-Tsague G, Kamgno J (2022) The first 30 days of COVID-19 vaccination in Cameroon: achievements, challenges, and lessons learned. The Pan African Medical Journal. https://doi.org/10.11604/pamj.2022.41.201.30218
[11] Malande OO, Munube D, Afaayo RN, Chemweno C, Nzoka M, Kipsang J, Musyoki AM, Meyer JC, Omayo LN, Owino-Okongo L (2021) Adverse events following immunization reporting and impact on immunization services in informal settlements in Nairobi, Kenya: a prospective mixed-methods study. Pan Afr Med J 40:81